Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 541–555 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-6262 PCSK9 Gene Hypercholesterolemia Autosomal Dominant Type 3 Genetic Test This genetic test identifies pathogenic variants in the PCSK9 gene associated with autosomal dominant hypercholesterolemia type 3.	Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic and likely pathogenic variants in the PCSK9 gene", "Copy Number Variations (CNVs) within the PCSK9 gene"] Parameters [] Preparation ["A detailed clinical history is required.", "A genetic counselling session to draw a pedigree chart is mandatory before sample collection."] Indications ["Individuals with LDL-C >190 mg/dL", "Family history of early heart disease", "Suspected familial hypercholesterolemia", "Risk stratification for cardiovascular disease", "Guidance for personalized lipid-lowering therapy", "Family cascade screening"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: E78.01 Clinical summary This genetic test identifies pathogenic variants in the PCSK9 gene associated with autosomal dominant hypercholesterolemia type 3.
TEST-5819 PDE8B Gene Striatal Degeneration Genetic Test This genetic test identifies pathogenic variants in the PDE8B gene associated with autosomal recessive striatal degeneration.	Whole blood (EDTA), extracted DNA, or FTA card spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PDE8B gene", "Full gene coding regions and flanking intronic sequences"] Parameters [] Preparation ["No fasting required", "Maintain hydration"] Indications ["Suspected autosomal recessive striatal degeneration", "Family history of striatal degeneration", "Differential diagnosis of neurodegenerative disorders"] Measurement technique Confirm with laboratory Codes LOINC: 58795-0 ICD-10: G23.8, G31.89 Clinical summary This genetic test identifies pathogenic variants in the PDE8B gene associated with autosomal recessive striatal degeneration.
TEST-3067 PDGFB Gene Sequencing Test This test identifies pathogenic variants in the PDGFB gene associated with Idiopathic Basal Ganglia Calcification Type 5 (IBGC5).	Peripheral Whole Blood (EDTA), Dried Blood Spot (FTA Card), or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PDGFB gene sequence", "Pathogenic variants (SNVs, indels, splice-site mutations)", "Coverage of coding exons, splice junctions, and regulatory regions"] Parameters [] Preparation ["Pre-test genetic counselling session required", "Detailed three-generation pedigree chart construction", "No fasting required unless combined with other metabolic tests"] Indications ["Individuals with bilateral basal ganglia calcification of unknown cause", "Positive family history suggestive of autosomal dominant inheritance", "Paediatric patients with unexplained developmental regression and cerebral calcifications", "Asymptomatic first-degree relatives of a confirmed IBGC5 proband seeking cascade screening"] Measurement technique Confirm with laboratory Codes LOINC: 21665-7 ICD-10: G23.8 Clinical summary This test identifies pathogenic variants in the PDGFB gene associated with Idiopathic Basal Ganglia Calcification Type 5 (IBGC5).
TEST-6134 PDHA1 (PDX1) and PDHX Gene Lacticacidemia Genetic Test This test evaluates the PDHA1 (PDX1) and PDHX genes for pathogenic variants associated with pyruvate dehydrogenase complex deficiency, a cause of primary lactic acidosis.	Peripheral EDTA whole blood (3–5 mL) or extracted genomic DNA (≥1 µg)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in PDHA1 (PDX1) gene", "Pathogenic variants in PDHX gene", "Single-nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy-number changes (CNVs)"] Parameters [] Preparation ["No specific fasting required for blood sample", "Inform lab of any current medications or dietary regimens"] Indications ["Individuals with unexplained chronic lactic acidosis", "Neonatal metabolic crises", "Family history of pyruvate dehydrogenase deficiency", "Carrier testing for at-risk relatives", "Preconception screening for couples with a family history of metabolic disorders"] Measurement technique Confirm with laboratory Codes LOINC: 81344-4 ICD-10: E74.81 Clinical summary This test evaluates the PDHA1 (PDX1) and PDHX genes for pathogenic variants associated with pyruvate dehydrogenase complex deficiency, a cause of primary lactic acidosis.
TEST-5912 PDHA1 Gene Pyruvate Dehydrogenase E1-Alpha Deficiency Genetic Test This test identifies pathogenic variants in the PDHA1 gene, confirming a diagnosis of pyruvate dehydrogenase E1-alpha deficiency.	Whole blood, extracted DNA, or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants (SNVs, indels, CNVs) in the PDHA1 gene"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medications without physician approval"] Indications ["Clinical suspicion of pyruvate dehydrogenase deficiency", "Family screening for confirmed cases", "Carrier testing for family members"] Measurement technique Confirm with laboratory Codes LOINC: 83107-8 ICD-10: E74.4 Clinical summary This test identifies pathogenic variants in the PDHA1 gene, confirming a diagnosis of pyruvate dehydrogenase E1-alpha deficiency.
TEST-5966 PEX1 Gene Zellweger Syndrome Genetic Test This test analyzes the PEX1 gene for pathogenic variants associated with Zellweger spectrum disorders using Next-Generation Sequencing (NGS). It provides a definitive molecular dia...	Whole Blood (preferred), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PEX1 gene sequence variants", "Copy number changes in PEX1 gene"] Parameters [] Preparation ["No specific fasting required", "Avoid sample collection during acute illness"] Indications ["Suspicion of Zellweger spectrum disorder", "Family history of peroxisomal biogenesis disorder", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 93277-8 ICD-10: E71.510 Clinical summary This test analyzes the PEX1 gene for pathogenic variants associated with Zellweger spectrum disorders using Next-Generation Sequencing (NGS). It provides a definitive molecular diagnosis, carrier status, and recurrence risk information.
TEST-5463 PEX11B Gene Peroxisome Biogenesis Disorder 14B Genetic Test This genetic test evaluates the PEX11B gene for pathogenic variants associated with peroxisome biogenesis disorder 14B.	Peripheral whole blood	3–4 weeks (fast-track available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PEX11B gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["No specific patient preparation required."] Indications ["Suspected peroxisome biogenesis disorder 14B", "Family history of peroxisomal disorders", "Carrier screening before pregnancy"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: E71.510, Q87.8 Clinical summary This genetic test evaluates the PEX11B gene for pathogenic variants associated with peroxisome biogenesis disorder 14B.
TEST-5886 PEX2 Gene Zellweger Syndrome Genetic Test This genetic test identifies pathogenic variants in the PEX2 gene associated with Zellweger syndrome spectrum disorders.	Peripheral Whole Blood (EDTA) or High-Quality Extracted DNA	3 – 4 Weeks (21 – 28 Days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PEX2 gene", "Copy number variations (CNVs) in the PEX2 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions (within 8 weeks)"] Indications ["Suspected Zellweger syndrome spectrum disorder", "Family history of peroxisomal biogenesis disorders", "Prenatal diagnosis", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 23862-2 ICD-10: E71.510 Clinical summary This genetic test identifies pathogenic variants in the PEX2 gene associated with Zellweger syndrome spectrum disorders.
TEST-5551 PEX3 Gene Peroxisome Biogenesis Disorder Type 10A Genetic Test This genetic test analyzes the PEX3 gene to identify pathogenic variants associated with peroxisome biogenesis disorder type 10A (Zellweger spectrum). It provides a definitive mole...	Peripheral Whole Blood (EDTA) or DNA FTA Card	21–28 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PEX3 gene", "Single-nucleotide variants", "Insertions", "Deletions", "Copy-number alterations"] Parameters [] Preparation ["No fasting required", "No specific medication or diet restrictions"] Indications ["Clinical suspicion of peroxisome biogenesis disorder type 10A (Zellweger spectrum)", "Family history of peroxisomal disorders", "Confirmation of biochemical findings suggestive of peroxisomal dysfunction"] Measurement technique Confirm with laboratory Codes LOINC: 102006-9 ICD-10: E71.518 Clinical summary This genetic test analyzes the PEX3 gene to identify pathogenic variants associated with peroxisome biogenesis disorder type 10A (Zellweger spectrum). It provides a definitive molecular diagnosis for neurodevelopmental and metabolic disorders.
TEST-5555 PEX5 Gene Peroxisome Biogenesis Disorder Type 2A Genetic Test This genetic test identifies pathogenic variants in the PEX5 gene associated with peroxisome biogenesis disorder type 2A.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PEX5 gene", "Single nucleotide variants", "Small indels", "Copy number variations"] Parameters [] Preparation ["Mandatory pre-test genetic counselling session required", "No dietary restrictions for sample collection"] Indications ["Confirmation of clinical diagnosis of PBD-2A", "Guiding management of peroxisomal disorders", "Genetic counseling for families with suspected PBD-2A", "Evaluation of patients with Zellweger spectrum disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21685-0 ICD-10: E71.5 Clinical summary This genetic test identifies pathogenic variants in the PEX5 gene associated with peroxisome biogenesis disorder type 2A.
TEST-5471 PEX5 Gene Peroxisome Biogenesis Disorder Type 2B Genetic Test This genetic test identifies pathogenic variants in the PEX5 gene associated with peroxisome biogenesis disorder type 2B.	Peripheral Whole Blood (3–5 mL in EDTA tube) or Validated DNA Blood Kit	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PEX5 gene", "Full gene coverage"] Parameters [] Preparation ["Complete a documented pre-test genetic counseling session", "Sign an informed consent form", "No fasting required"] Indications ["Suspected peroxisome biogenesis disorder type 2B", "Zellweger spectrum disorder diagnosis", "Patients with neurological, hepatic, and adrenal symptoms consistent with peroxisomal dysfunction"] Measurement technique Confirm with laboratory Codes LOINC: 87809-3 ICD-10: E71.5 Clinical summary This genetic test identifies pathogenic variants in the PEX5 gene associated with peroxisome biogenesis disorder type 2B.
TEST-5889 PEX6 Gene Zellweger Syndrome Genetic Test This genetic test sequences the PEX6 gene to identify pathogenic variants associated with Zellweger spectrum disorders.	Peripheral Whole Blood or FTA Card (Dried Blood Spot)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PEX6 gene sequence", "Pathogenic variants in PEX6"] Parameters [] Preparation ["Do not discontinue prescribed medication without consulting your doctor"] Indications ["Suspected Zellweger spectrum disorder", "Family history of peroxisomal biogenesis disorders", "Need for definitive molecular confirmation"] Measurement technique Confirm with laboratory Codes LOINC: 69548-6 ICD-10: E71.510 Clinical summary This genetic test sequences the PEX6 gene to identify pathogenic variants associated with Zellweger spectrum disorders.
TEST-2994 PHOX2A Gene Central Hypoventilation Syndrome Genetic Test This test identifies pathogenic variants in the PHOX2A gene, which are the primary cause of Congenital Central Hypoventilation Syndrome (CCHS).	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PHOX2A gene", "Coding exons and splice junctions of the PHOX2A gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications that might interfere with DNA extraction"] Indications ["Neonates, infants, and children with unexplained hypoventilation", "Infants with cyanotic episodes or apnea", "Family members of confirmed CCHS patients"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G47.35 Clinical summary This test identifies pathogenic variants in the PHOX2A gene, which are the primary cause of Congenital Central Hypoventilation Syndrome (CCHS).
TEST-4229 PHOX2B Gene Central Hypoventilation Syndrome with or without Hirschsprung Disease Genetic Test This test evaluates the PHOX2B gene for pathogenic variants associated with Congenital Central Hypoventilation Syndrome (CCHS) and Hirschsprung disease.	Whole Blood (EDTA) or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PHOX2B gene variants (SNVs, indels, CNVs)", "Diagnostic sensitivity for CCHS/Hirschsprung disease"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Diagnosis of CCHS", "Diagnosis of Hirschsprung disease", "Pre-symptomatic testing for at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 92746-2 ICD-10: G47.35, Q43.1 Clinical summary This test evaluates the PHOX2B gene for pathogenic variants associated with Congenital Central Hypoventilation Syndrome (CCHS) and Hirschsprung disease.
TEST-3946 PHOX2B Gene Sequencing Test This test identifies mutations in the PHOX2B gene, the primary cause of Congenital Central Hypoventilation Syndrome (CCHS). It detects both common and rare variants associated with...	Whole Blood (EDTA), Extracted DNA, or One Drop Blood on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PHOX2B gene sequence", "Polyalanine repeat length", "Non-PARM sequence variants", "Copy number analysis"] Parameters [] Preparation ["Mandatory genetic counselling session prior to sample collection", "Detailed pedigree chart construction"] Indications ["Suspected Congenital Central Hypoventilation Syndrome (CCHS)", "Evaluation of autonomic respiratory control disorders", "Screening for Hirschsprung disease in CCHS patients", "Family planning for individuals with CCHS"] Measurement technique Confirm with laboratory Codes LOINC: 59099-9 ICD-10: G47.35, Q43.1, Z13.71 Clinical summary This test identifies mutations in the PHOX2B gene, the primary cause of Congenital Central Hypoventilation Syndrome (CCHS). It detects both common and rare variants associated with the disorder.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.